Akorn (AKRXQ) Stock Price, News & Analysis

Company Overview

Akorn, Inc. was a specialty pharmaceutical company focused on developing, manufacturing and marketing prescription and over-the-counter medicines. Its product portfolio historically included generic and branded pharmaceuticals, with an emphasis on ophthalmic products, injectable medicines, oral liquids and other specialized dosage forms.

The company served hospitals, physicians, pharmacies, wholesalers and other health care providers, primarily in the United States. Akorn operated manufacturing and research facilities in the U.S. and had also maintained international operations and commercial relationships.

Akorn experienced significant financial and operational difficulties in the late 2010s and early 2020s. It entered bankruptcy proceedings and its business was subsequently restructured and sold. The company’s common stock trades over the counter under the symbol AKRXQ, and publicly available information about its current operations and leadership is limited.

Key Stats

• Today's Range: $0.03 to $0.03
• 50-Day Range: $0.03 to $0.03
• 52-Week Range: $0.01 to $5.40
• Volume: N/A
• Average Volume: 7.44 million shs
• Market Capitalization: $3.60 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 10/16/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:AKRXQ
• CIK: N/A
• Web: www.akorn.com
• Phone: 847-279-6100
• Fax: 800-943-3694
• Employees: 2,191
• Year Founded: 1948

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $682.43 million
• Price / Sales: 0.01
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 133,451,000
• Free Float: 128,246,000
• Market Cap: $3.60 million
• Optionable: Not Optionable
• Beta: N/A